Tauber Eye Center

Tauber Eye Center is a premier ophthalmology practice and clinical research facility based in Kansas City, Missouri. Founded and led by Dr. Joseph Tauber, a globally recognized expert in ocular surface disease, the center serves as a high-volume site for Phase 2 and Phase 3 clinical trials. The facility has participated in over 150 research studies, contributing significantly to the development and FDA approval of major ophthalmic therapies such as Restasis, Xiidra, and Miebo. Tauber Eye Center provides specialized clinical care for complex corneal conditions, dry eye, uveitis, and refractive surgery while maintaining a robust research infrastructure for pharmaceutical and biotech partners. The center is a key partner for major pharmaceutical companies seeking high-quality clinical data for anterior segment and ocular surface innovations.